Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17905235 | 0.91 | TSHR (0.32) | TSHRCHRM2CHRM4CHRM1LMNA | |
| SCHEMBL30899719 | 0.91 | TSHR (0.32) | TSHRTDP1 | |
| SCHEMBL28851108 | 0.86 | TDP1 (0.45) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL27625695 | 0.84 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL20101942 | 0.83 | ALDH1A1 (0.34) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL2249045 | 0.83 | ALDH1A1 (0.34) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| SCHEMBL246951 | 0.82 | TSHR (0.45) | TSHRALDH1A1 | |
| SCHEMBL41548 | 0.81 | TSHR (0.52) | TSHRALDH1A1LMNAMAPTCYP2C9 | |
| SCHEMBL27646157 | 0.81 | TSHR (0.33) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL16181835 | 0.81 | GRIN2D (0.35) | TSHRALDH1A1CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126419-A | Radial bicycle pneumatic tire and preparation process thereof | 黑猫轮胎(福建)有限公司 | 2024-06-04 | — | — | CN | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| EP-0328158-B1 | A METHOD FOR IMPROVING THE RELEASE OF A CAST CONCRETE ITEM FROM THE MOULD BY APPLYING TO THE MOULD A MOULD RELEASE COMPOSITION | CASTROL A/S (DK) | 1993-06-30 | — | — | EP | claimed |
| EP-0180630-B1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | CASTROL A/S (DK) | 1991-10-09 | — | — | EP | claimed |
| EP-0328158-A1 | A method for improving the release of a cast concrete item from the mould by applying to the mould a mould release composition | CASTROL A/S (DK) | 1989-08-16 | — | — | EP | claimed |
| EP-0180630-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD. | KOEGE KEMISK VAERK (DK) | 1986-05-14 | — | — | EP | claimed |
| WO-1985005066-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | KEMISK VA^ERK KO^/GE A/S (DK) | 1985-11-21 | — | — | WO | claimed |
| CN-118126419-B | Radial bicycle pneumatic tire and preparation process thereof | 黑猫轮胎(福建)有限公司 | 2025-10-31 | — | — | CN | disclosed |
| US-20250319063-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | PMV PHARMACEUTICALS, INC. | 2025-10-16 | — | — | US | disclosed |
| CN-118126419-A | Radial bicycle pneumatic tire and preparation process thereof | 黑猫轮胎(福建)有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118126419-A | Radial bicycle pneumatic tire and preparation process thereof | 黑猫轮胎(福建)有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-112368259-A | Isobutyrate compound having butyryloxy group or pivaloyloxy group at alpha-position, and fragrance composition | 三菱瓦斯化学株式会社 | 2021-02-12 | — | — | CN | disclosed |
| EP-1920042-B1 | PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCED PROPERTIES | HENKEL AG & CO KGAA (DE) | 2010-06-23 | — | — | EP | disclosed |
| WO-1992009197-A1 | STABILIZED HERBICIDE COMPOSITIONS | KVK AGRO A/S (DK) | 1992-06-11 | — | — | WO | disclosed |
| US-5100697-A | METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | CASTROL A/S (DK) | 1992-03-31 | — | — | US | disclosed |
| EP-0180630-B1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | CASTROL A/S (DK) | 1991-10-09 | — | — | EP | disclosed |
| EP-0328158-A1 | A method for improving the release of a cast concrete item from the mould by applying to the mould a mould release composition | CASTROL A/S (DK) | 1989-08-16 | — | — | EP | disclosed |
| EP-0180630-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD. | KOEGE KEMISK VAERK (DK) | 1986-05-14 | — | — | EP | disclosed |
| WO-1985005066-A1 | A METHOD FOR IMPROVING THE RELEASE OF A MOULDED CONCRETE BODY FROM THE MOULD | KEMISK VA^ERK KO^/GE A/S (DK) | 1985-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319063-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | TP53, TP53BP1, KRAS | TSHR 3837/4885ALDH1A1 1428/4885CHRM2 4529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.